Abstract:The design and development of contrast agents for magnetic resonance imaging (MRI) with improved chemical stability and higher contrasting capability for clinical translation compared to conventional contrast agents are still of great interest. In this study, a facile and universal approach was explored for controllable functionalization of red-emissive carbon nanodots (RCNDs) with diethylenetriaminepentaacetic anhydride (DTPA) for chelation of gadolinium. A series of accurate characterizations were used to control each step of the synthesis. The functionalization did not alter the band gap of the carbon nanodots, preserving their inherent far-red fluorescence. The as-prepared RCND-DTPA-Gd displayed a high colloidal stability with negligible Gd leakage. The nanodots also showed a better magnetic resonance relaxivity than commercial MRI agents. RCND-DTPA-Gd had good biocompatibility <i>in vivo</i> even at high doses. The systemically injected RCND-DTPA-Gd were found to be efficiently excreted through the renal route, a feature that further minimizes the potential toxicity risks. All these properties suggest that carbon nanodots can be well designed as efficient carriers of Gd, resulting in potential clinical tools as dual MRI/fluorescence functional probes for imaging applications. The approach described here could pave the pathway to a flexible strategy for the controllable functionalization of small-sized nanoparticles including carbon dots, rendering them more versatile. This work is expected to promote the future translation of carbon nanodots into clinical trials.The Supporting Information is available free of charge at <a class="ext-link" href="/doi/10.1021/acsanm.0c02993?goto=supporting-info">https://pubs.acs.org/doi/10.1021/acsanm.0c02993</a>.Organ distribution of RCND-DTPA-Gd in vivo (Videos S1 and S2) (<a class="ext-link" href="/doi/suppl/10.1021/acsanm.0c02993/suppl_file/an0c02993_si_001.zip">ZIP</a>)Synthesis of DTPA ligand (Scheme S1), additional HAADF-STEM images of the RCND-DTPA-Gd sample (Figure S1), DLS of RCND-DTPA-Gd (Figure S2), FL spectra of CND-DTPA-Gd (Figure S3), cell viability of RCND-DTPA-Gd (Figure S4), and the hematological and biochemical parameters of RCND-DTPA (Tables S1 and S2) (<a class="ext-link" href="/doi/suppl/10.1021/acsanm.0c02993/suppl_file/an0c02993_si_002.pdf">PDF</a>)This article has not yet been cited by other publications.

Kilogram‐Scale Synthesis of Extremely Small Gadolinium Oxide Nanoparticles as a T 1 ‐Weighted Contrast Agent for Magnetic Resonance Imaging

Kilogram scale facile synthesis and systematic characterization of a Gd-macrochelate as T1-weighted magnetic resonance imaging contrast agent

Exceedingly Small Gadolinium Oxide Nanoparticles with Remarkable Relaxivities for Magnetic Resonance Imaging of Tumors

Synthesis of a Highly Stable Gadolinium Based MRI Contrast Agent

A neutral polydisulfide containing Gd(III) DOTA monoamide as a redox‐sensitive biodegradable macromolecular MRI contrast agent

Preparation of MRI-visible Gadolinium Methacrylate Nanoparticles with Low Cytotoxicity and High Magnetic Relaxivity

Stable Gadolinium Based Nanoscale Lyophilized Injection for Enhanced MR Angiography with Efficient Renal Clearance

Ultrasmall gadolinium hydrated carbonate nanoparticle: An advanced T 1 MRI contrast agent with large longitudinal relaxivity

Gadolinium-Incorporated Carbon Nanodots for T 1 -Weighted Magnetic Resonance Imaging

Geometrical Confinement of Gadolinium Oxide Nanoparticles in Poly(ethylene Glycol)/arginylglycylaspartic Acid-Modified Mesoporous Carbon Nanospheres As an Enhanced T1 Magnetic Resonance Imaging Contrast Agent.

Stimuli-Responsive Biodegradable Hyperbranched Polymer–Gadolinium Conjugates as Efficient and Biocompatible Nanoscale Magnetic Resonance Imaging Contrast Agents

Formation of Nanosized Gd(III) Coordination Networks with Tripodal Amine-N-oxide Type Ligand Through Microemulsions to Achieve High Relaxivity and Exceptional Stability for MRI Applications

Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor <i>T</i><sub>1</sub> Magnetic Resonance Imaging

Single-Atom Gadolinium Nano-Contrast Agents with High Stability for Tumor T 1 Magnetic Resonance Imaging

Gadolinium (III)-Chelated Deformable Mesoporous Organosilica Nanoparticles as Magnetic Resonance Imaging Contrast Agent.

Biocompatible Nanoparticles of KGd(H2O)2[Fe(CN)6]·H2O with Extremely High T1-Weighted Relaxivity Owing to Two Water Molecules Directly Bound to the Gd(III) Center

Controlled Self-Assembling Of Gadolinium Nanoparticles As Smart Molecular Magnetic Resonance Imaging Contrast Agents

Continuous Synthesis of Extremely Small-Sized Iron Oxide Nanoparticles Used for T1-weighted Magnetic Resonance Imaging Via a Fluidic Reactor

Gd-Dots with Strong Ligand-Water Interaction for Ultrasensitive Magnetic Resonance Renography

Outstanding MRI contrast with dysprosium phosphate nanoparticles of tuneable size

Exceedingly small iron oxide nanoparticles as positive MRI contrast agents